Elizabeth King, MD

Board Certifications

• American Board of Internal Medicine (ABIM)
• Endocrinology, Diabetes, & Metabolism

Fellowship

The University of Texas Health Science Center
Endocrinology, Diabetes, and Metabolism
San Antonio, 2007-2009

Internship and Residency

The University of Texas Health Science Center
Internal Medicine

Medical School

University of Texas Medical School
San Antonio, 2003

Undergraduate School

University of Texas at Austin
Bachelor of Business Administration, Finance
Cum Laude, 1999

• Endocrinologist, Endocrine Associates of Dallas
• Texas Health Presbyterian Hospitals, Dallas and Plano

• 2011-2014 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Southwestern Medical Center
• 2009-2011 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Health Science Center at San Antonio
• 2006-2011 Chief Resident/Clinical Instructor, Department of Medicine, The University of Texas Health Science Center at San Antonio

Texas Medical Association
International Society for Clinical Densitometry

State of Texas

• 2009 Research Day Winner, Clinical Fellows, UTHSCSA Dept. of Medicine Research Day
• 2009 Endocrine Society Travel Grant
• 2007-2008 “Top 25” ACES Preceptor Award, awarded by UTHSCSA MS2 class
• 2005 Gold Humanism Honor Society
• 2005-2006 Teaching Award, awarded by UTHSCSA MS3 class
• 2003-2004 Intern of the Year, UTHSCSA, awarded by internal medicine residents
• 2003-2004 Compassion Award, UTHSCSA awarded by internal medicine residents
• 2003-2004 Teaching Award, awarded by UTHSCSA MS3 class
• 2003-2004 Excellence in Clinical Geriatrics, awarded by UTHSCSA geriatric faculty
• 1999-2003 Houston Northwest Medical Center Auxiliary Scholarship for Students Entering Health, Health Science, and Medical Fields
• 1995-1999 National Merit Scholarship Corporation Special Scholarship, Shell Oil Company

• Board Member, PTA, Hyer Elementary School
• Advisor, Kappa Kappa Gamma, Gamma Phi Chapter

• 2016-present Endocrinologist, Endocrine Associates of Dallas
• 2011-2014 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Southwestern Medical Center
• 2009-2011 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Health Science Center at San Antonio
• 2006-2011 Chief Resident/Clinical Instructor, Department of Medicine, The University of Texas Health, Science Center at San Antonio

The University of Texas Health Science Center at San Antonio, Department of Medicine/Hematology and Oncology

• Translational research focused on genetic predisposition to pheochromocytoma and paraganglioma, Principal Investigator: Patricia Dahia, MD/PhD, Dates: 2007-2009

The University of Texas Southwestern Medical Center

• Sub-investigator, “A phase III, multicenter, randomized, parallel-group study to assess the efficacy and safety of double-blind pasireotide LAR 40mg and pasireotide LAR 60mg versus open-label octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly,”, Novartis Pharmaceuticals, Dates: 2012-2014

Certified Clinical Densitometrist, International Society for Clinical Densitometry

2014-present Clinical Volunteer Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Southwestern Medical Center

Publications

Kadiyala S, Khan Y, de Miguel V, Frone MN, Nwariaku F, Rabaglia J, Woodruff S, King EE, Hathiramani SS, Pacak K, and Ghayee HK. SDHD mutation: looking beyond head and neck tumors. AACE Clinical Case Reports 2017. https://doi.org/10.4158/EP172003.CR

King EE, Qin Y, Toledo RA, Luo A, Ball E, Faucz FR, Janeway KA, Stratakis CA, Tomlinson GE, Dahia PL.  Integrity of the pheochromocytoma susceptibility TMEM127 gene in patients with pediatric malignancies.  Endocrine Related Cancer 2015; 22(3): L5-7.

Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Perez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacche M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SPA, Maher ER, Mannelli M, Opocher G, Robledo M, Dahia PLM. Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas.  JAMA 2010; 304(23): 2611-2619.

Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SPA, Stiles C, Aguiar RCT, Dahia PLM. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.  Nature Genetics 2010; 42(3): 229-233. 

King EE, Dahia PLM.  Molecular biology of pheochromocytomas and paragangliomas In: Lloyd RV (ed).  Endocrine Pathology: Differential Diagnosis and Molecular Advances, 2^nd Edition. New York: Springer: 2009. p. 297-305.

King EE, King CA. Long white coat marks transition. San Antonio Medicine 2004; 57:32-34.

Abstracts/Presentations

Hussein I, King EE, Mirfakhraee S. Mifepristone as a bridging therapy to gamma knife radiosurgery in recurrent Cushing’s disease. Abstract, Endocrine Society Meeting, San Diego, 2015.

Basani S, King EE, Mirfakhraee S. Mifepristone for preoperative treatment of hypercortisolism from Cushing’s disease: a case report. Abstract, Endocrine Society Meeting, San Diego, 2015.

DeGueme AM, King EE, Mirfakhraee S. Medical treatment of Cushing’s disease with mifepristone: a clinical case series. Abstract, Endocrine Society Meeting, San Diego, 2015.

King EE and Howell SM. Clinical management in a female with persistent Cushing’s disease treated with mifepristone for four years.  Abstract, Endocrine Society Meeting, Chicago, 2014.

King EE, Hashim IA, Auchus RJ, Xie XJ, Christie A, Castanon R, Brophey MD, Ghayee HK. Value of ACTH distinguishing pituitary versus ectopic causes of Cushing’s syndrome. Abstract, Endocrine Society Meeting, Chicago, 2014.

Chokshi N, Maekawa T, Sasano H, Carrick K, Woodruff S, Rabaglia J, Nwariaku F, Ghayee HK, King EE. Benign Cortisol Producing Adrenal Adenomas Co-Secreting Salt or Sex Hormones. Abstract, Endocrine Society Meeting, San Francisco, 2013.

Ghayee HK, Farley M, Nwariaku F, Woodruff S, Rabaglia J, King EE, Hathiramani S. Bilateral pheochromocytomas in a patient with SDHD mutation. Abstract, Endocrine Society Meeting, San Francisco, 2013.

Shulman RM, Meyn S, Druker H, Malkin D, Gerstle TJ, Hwa V, Fofanova-Gambetti OV, Dahia P, Rosenfeld R, King EE, Hamilton J.  The short and the sweaty: a case of familial pheochromocytoma and growth hormone gene mutation. Abstract, Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology Meeting, New York, 2009.

King E, Dahia P, Tischler A. The new putative pheochromocytoma/neuroblastoma susceptibility gene KIF1Bb is infrequently mutated in pheochromocytomas associated with other malignancies.  Abstract, Endocrine Society Meeting, Washington, D.C., 2009 AND Oral/Poster Presentation—12th Annual UTHSCSA Department of Medicine Research Day 2009.

Bischoff B, King E, Simcic K, Crawford G.  Two cases of pheochromocytoma in males with NF1 presenting with adrenal incidentalomas. Abstract 15^th Annual South Texas ACP Associates Program 2008 AND 11^th Annual UTHSCSA Department of Medicine Research Day, San Antonio, Texas, 2008

King E. Oral Case Presentation, Thyroid Function/Graves Disease,78^th Annual Meeting of the American Thyroid Association, Fellows’ Track, New York, 2007

King E, Perkins W. Rapid development of hepatic and splenic abscesses in a woman with hereditary hemorrhagic telangiectasia syndrome.  Abstract, 12^th Annual South Texas ACP Associates Program 2005 AND 8^th Annual Department of Medicine Research Day, San Antonio, Texas, 2005.

Edrington (King) E, Bruder JM.  Effects of the hypogonadal state on lipid levels in patients treated for prostate cancer.  Abstract, 6^th Annual Department of Medicine Research Day, San Antonio, Texas, 2003.    

Invited Lectures

• 2018      “Pituitary Incidentaloma: Evaluation and Management” Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
• 2016     “Polycystic Ovarian Syndrome: What Are the Problems and How Do We Solve Them?”, Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
• 2015     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” Texas AACE Meeting for Primary Care Providers, Austin, Texas
• 2015     “When Things Get Interesting: Cushing’s Outside the Pituitary,” Texas AACE Meeting, Austin, Texas
• 2014     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” Update in Internal Medicine Conference, UTSW, Dallas, Texas
• 2014     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
• 2014     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” UTSW Endocrinology Grand Rounds, Dallas, Texas
• 2013     “Pituitary and Adrenal Incidentalomas,” Update in Internal Medicine, UTSW, Dallas, Texas
• 2013     “Pheochromocytoma in 2013: What We Know and What We Need to Learn,” Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
• 2012     “Molecular Aspects of Pheochromocytoma: What We Know and What We Need to Learn,”, UTSW Endocrinology Grand Rounds, Dallas, Texas
• 2012     “Pheochromocytoma in 2012: Diagnosis and Management,” TexMed 2012, Texas Medical Association, Dallas, Texas
• 2011     “PCOS: A Review,” UTHSCSA Endocrinology Grand Rounds, San Antonio, Texas
• 2010     “Pheochromocytoma: An Update,” UTHSCSA Endocrinology Grand Rounds, San Antonio, Texas
• 2010     “The Adrenal Incidentaloma—Cushing’s, Pheo, Hyperaldo! Oh My!” UTHSCSA Internal Medicine Grand Rounds, San Antonio, Texas
• 2010     “Diagnosis and Management of Common Thyroid Disorders,” UTHSCSA School of Nursing Continuing Education, San Antonio, Texas
• 2009     “Cushing’s Syndrome,” UTHSCSA Endocrinology Grand Rounds, San Antonio, Texas
• 2009     “Diabetes and Lipids,” ACP Internal Medicine Board Review, San Antonio, Texas
• 2008     “Molecular Basis of Pheochromocytoma,” UTHSCSA Endocrinology Grand Rounds, San
• Antonio, Texas

Continuing Medical/Dental/Specialty Education Conferences and eConferences

• Endocrine Society Annual Meeting, Orlando, FL 2017
• Texas AACE/TESS Annual Meeting, Dallas, TX 2016
• Texas AACE/TESS Annual Meeting, Austin, TX 2015
• Endocrine Society Annual Meeting, San Francisco, CA 2013
• Endocrine Society Annual Meeting, Washington, D.C., 2009

Dr. King is married to Carter, an interventional cardiologist, and they have two daughters. In her free time, she enjoys spending time with her family and friends, playing tennis, enjoying the outdoors, and traveling. She is a member of and attends Park Cities Presbyterian Church.

A native Texan, Dr. Elizabeth King was born and raised in Houston. She graduated magna cum laude from Westfield High School and then attended The University of Texas at Austin, earning a bachelor of business administration in finance with honors in 1999. Dr. King graduated from the University of Texas Medical School at San Antonio in 2003 and stayed at the University of Texas Health Science Center at San Antonio (UTHSCSA) to pursue her postgraduate training in internal medicine where she also served as chief resident. She then completed her fellowship in endocrinology, diabetes, and metabolism at UTHSCSA in 2009.

Dr. Elizabeth King served on the faculty at UTHSCSA for two years prior to relocating with her family to Dallas in 2011. From 2011-2014, she was a member of the faculty in the Department of Internal Medicine/Division of Endocrinology at the University of Texas Southwestern Medical School. She was pleased to join Endocrine Associates of Dallas in 2016.